{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:23:14Z","timestamp":1761402194215,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.clinph.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T04:41:48Z","timestamp":1626928908000},"page":"2932-2933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nodal conduction block and reversible conduction failure are not electrophysiological markers for axonal loss"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7989-6107","authenticated-orcid":false,"given":"Shin J.","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2021.07.008_b0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410440210","article-title":"IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain Barre syndrome","volume":"44","author":"Kuwabara","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinph.2021.07.008_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.26122","article-title":"Electrophysiologic lessons from the European multicenter study of Guillain-Barre subtype diagnosis","volume":"58","author":"Lewis","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2021.07.008_b0015","doi-asserted-by":"crossref","unstructured":"Oh SJ. Clinical Electromyography: Nerve conduction study. 3rd ed. Philadelphia, USA: Lippincott Williams & Wilkins; 2003.","DOI":"10.1046\/j.1468-1331.2003.00654.x"},{"issue":"2","key":"10.1016\/j.clinph.2021.07.008_b0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mus.27115","article-title":"Nodal conduction block, a unifying concept","volume":"63","author":"Oh","year":"2021","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.clinph.2021.07.008_b0025","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.clinph.2020.07.014","article-title":"The electrophysiology of axonal neuropathies: more than just evidence of axonal loss","volume":"131","author":"Uncini","year":"2020","journal-title":"Clin Neurophysiol"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245721006556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245721006556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:05:55Z","timestamp":1761393955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245721006556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":5,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1388245721006556"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2021.07.008","relation":{},"ISSN":["1388-2457"],"issn-type":[{"type":"print","value":"1388-2457"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nodal conduction block and reversible conduction failure are not electrophysiological markers for axonal loss","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V. on behalf of International Federation of Clinical Neurophysiology.","name":"copyright","label":"Copyright"}]}}